Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
B007
/
Shanghai Pharma
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||||||||
||
B007
/
Shanghai Pharma
New P2/3 trial:
SPH-B007-303: A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
(clinicaltrials.gov) - Jun 7, 2024
P2/3
, N=104, Not yet recruiting,
Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd
|||
|||||||
B007
/
Shanghai Pharma
Enrollment open:
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
(clinicaltrials.gov) - Mar 24, 2023
P1
, N=52, Recruiting,
Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd
Not yet recruiting --> Recruiting
|||
|||||||
B007
/
Shanghai Pharma
New P1 trial:
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
(clinicaltrials.gov) - Dec 29, 2022
P1
, N=52, Not yet recruiting,
Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd